The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global anti-vascular endothelial growth factor therapeutics market is expected to grow from $12.01 billion in 2022 to $12.18 billion in 2023 at a compound annual growth rate (CAGR) of 1.4%. The global anti-vascular endothelial growth factor therapeutics market size is expected to reach $12.8 billion in 2027 at a CAGR of 1.2%.

North America held the largest anti-vascular endothelial growth factor therapeutics market share, and Europe was the fastest-growing region in 2022.

Anti-Vascular Endothelial Growth Factor Therapeutics Market Driver
The rising frequency of ocular illnesses is likely to drive the anti-vascular endothelial growth factor therapies market forward. The quantity or proportion of people in a certain population who have been diagnosed with or display specific eye ailments or diseases is referred to as the prevalence of ophthalmic diseases. Anti-vascular endothelial growth factor (VEGF) treatments can lower the prevalence of ocular illnesses by effectively treating conditions such as wet AMD, diabetic retinopathy, and retinal vein occlusion. According to the World Health Organisation, a Switzerland-based international public health organisation, around 2.2 billion people worldwide have near or distant vision impairment in October 2022, and 1 billion individuals suffer from close or distance visual impairment. Moreover, 88.4 million have refractive error, 94 million have cataracts, 8 million have age-related macular degeneration, and around 3.9 million have diabetic retinopathy. As a result, the rising prevalence of ocular illnesses is propelling the anti-vascular endothelial growth factor therapies market forward.

View More On The Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Prominent Anti-Vascular Endothelial Growth Factor Therapeutics Market Trend
Therapeutic advancements are a significant trend gaining traction in the anti-vascular endothelial growth factor therapies market. Companies in the anti-vascular endothelial growth factor therapies market are utilising sophisticated medicines to maintain their market position. For example, Ashvattha Therapeutics Inc, a clinical-stage biopharmaceutical business based in the United States, reported phase 1 safety data for healthy people for subcutaneous anti-VEGF wet AMD (age-related macular degeneration) and DME (diabetic macular edoema) candidates in May 2022. D-4517.2 therapy is a first-of-its-kind therapy designed to meet the unmet needs of DME patients. D-4517.2 treatment with an autoinjector is being developed for self-administration. Patients can self-administer the drug once a month in the comfort of their own home using the autoinjector D-4517.2.

Anti-Vascular Endothelial Growth Factor Therapeutics Market Prominent Players
Major players in the anti-vascular endothelial growth factor therapeutics market are F. Hoffmann-La Roche AG, Biogen Inc., Pfizer Inc., Coherus BioSciences Inc., Applied Molecular Genetics Inc., Eli Lilly, Bausch Health Companies Inc., Viatris Inc., Xbrane Biopharma AB, Bayer AG, Regeneron Pharmaceuticals Inc., Genentech Inc, Allergan Inc., and Novartis AG.

Request A Sample Of The Global Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10683&type=smp

Key Anti-Vascular Endothelial Growth Factor Therapeutics Market Segments
The global anti-vascular endothelial growth factor therapeutics market is segmented –
1) By Product: Eylea, Lucentis, Beovu
2) By Disease: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration
3) By End Users: Hospitals, Clinics, Oncology Centers, Other End Users

The Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2023  provides a comprehensive overview on the anti-vascular endothelial growth factor therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the anti-vascular endothelial growth factor therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
AntiHypertensive Drugs Global Market Report 2023
Vascular Grafts Global Market Report 2023
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model